CuroNZ is dedicated to revolutionizing the treatment landscape for refractory epilepsies and difficult-to-treat encephalopathies by leveraging our proprietary Neuronal Regeneration Peptides (NRPs). Our pipeline includes NRP2945, which is entering clinical phase 2 for adult patients with drug-resista...See more
Headquarters:
New Zealand
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2010 (16 years)
Address:
RUAKURA RD; HAMILTON, WAIKATO, NZ
LOW
spending power
